Array BioPharma Inc. (NASDAQ:ARRY) stock has seen a rise as of late. Shares have hit a new 52-week high after reaching $10.87 during recent trading action. Investors will be watching to see if the name can maintain momentum heading into the new year.
Share Performance Summary
Since the start of the calendar year, Array BioPharma Inc. (NASDAQ:ARRY)’s stock has changed 23.66%. Over the last five trading sessions, the stock has moved 21.59%. For the past month, Array BioPharma Inc.’s stock has been 29.40%, 59.85% for the last quarter, 193.78% for the past six months and 224.48% for the past 52 weeks.
Based on current stock levels, Array BioPharma Inc. shares are trading 7.09% off of the 50-day high and 102.80% away from the 50-day low.
Earnings Per Share (EPS), the portion of a company’s profit distributed to each outstanding common share, is a useful indicator of a company’s profitability. EPS is typically considered to be the most important variable in determining a share’s price. Array BioPharma Inc. (NASDAQ:ARRY)’s EPS growth this year is -18.50% and the trailing 12-month EPS is $-0.70. Covering sell-side analysts are estimating company growth for next year to be 0.00%. On a consensus basis, analysts have given a recommendation of 1.60 on company shares.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.